Natural Product: NPC475029

Natural Product IDNPC475029
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Nahocol D2
IUPAC Name methyl 2-[2-[(6E,10E,12R,13R)-12,13-dihydroxy-3,7,11,15-tetramethylhexadeca-1,6,10,14-tetraen-3-yl]oxy-5-hydroxyphenyl]acetate
Synonyms Nahocol D2
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL492852
PubChem CID 10672589
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey OXEKXGDCBFXSKR-IYEDCBBRSA-N
Standard InCHI InChI=1S/C29H42O6/c1-8-29(6,35-26-15-14-24(30)18-23(26)19-27(32)34-7)16-10-12-21(4)11-9-13-22(5)28(33)25(31)17-20(2)3/h8,12-15,17-18,25,28,30-31,33H,1,9-11,16,19H2,2-7H3/b21-12+,22-13+/t25-,28-,29?/m1/s1
SMILES COC(=O)Cc1cc(O)ccc1OC(CC/C=C(/CC/C=C(/[C@H]([C@@H](C=C(C)C)O)O)C)C)(C=C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   486.3 Volume:   533.233
?
Van der Waals volume.
Dense:   0.912 LogP:   4.869
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.845
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.829
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   15.0 Rigid Bonds:   11.0
TPSA:   96.22
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   3.0 Rings:   1.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.235 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.392 Fsp3:   0.483
MCE-18:   30.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.974 Fluc inhibitor:   0.013
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.03
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.184
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.369 Promiscuous compounds:   0.077

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.842 MDCK Permeability:   -4.802
Pgp-inhibitor:   0.808 Pgp-substrate:   0.0
PAMPA:   0.015
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.002
20% Bioavailability (F20%):   0.16 30% Bioavailability (F30%):   0.187
50% Bioavailability (F50%):   0.99

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.868
Plasma Protein Binding (PPB):   94.562% Volume Distribution (VD):   0.102
Fu: 4.873%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.0
BSEP inhibitor:   0.982

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.001
CYP2C19-inhibitor:   0.031 CYP2C19-substrate:   0.212
CYP2C9-inhibitor:   0.008 CYP2C9-substrate:   0.048
CYP2D6-inhibitor:   0.039 CYP2D6-substrate:   0.165
CYP3A4-inhibitor:   0.017 CYP3A4-substrate:   0.038
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.967
HLM stability:   0.994
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.924 Half-life (T1/2):  0.964

ADMET: Toxicity

hERG Blockers:  0.07 hERG Blockers (10um):  0.591
Human Hepatotoxicity (H-HT):  0.567 Drug-induced Liver Injury (DILI):  0.019
AMES Toxicity:  0.135 Rat Oral Acute Toxicity:  0.199
Maximum Recommended Daily Dose:  0.164 Skin Sensitization:  0.981
Carcinogencity:  0.038 Eye Corrosion:  0.0
Eye Irritation:  0.314 Respiratory Toxicity:  0.74
Drug-induced Neurotoxicity:  0.135 Ototoxicity:  0.674
Hematotoxicity:  0.136 Drug-induced Nephrotoxicity:  0.309
Genotoxicity:  0.271 RPMI-8226 Immunitoxicity:  0.045
A549 Cytotoxicity:  0.045 Hek293 Cytotoxicity:  0.272
BCF:   1.89
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.731
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.261
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.604
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11479 Sargassum siliquastrum Species Sargassaceae Eukaryota n.a. n.a. n.a. PMID[15921416]
NPO11479 Sargassum siliquastrum Species Sargassaceae Eukaryota n.a. subtidal zone (0-2 m) off the southwestern shore of Jeju Island, Korea 2003-Apr PMID[18817444]
NPO11479 Sargassum siliquastrum Species Sargassaceae Eukaryota n.a. n.a. n.a. PMID[19006667]
NPO11479 Sargassum siliquastrum Species Sargassaceae Eukaryota n.a. n.a. n.a. PMID[21377877]
NPO11479 Sargassum siliquastrum Species Sargassaceae Eukaryota n.a. n.a. n.a. PMID[28720331]
NPO11479 Sargassum siliquastrum Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO11479 Sargassum siliquastrum Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1087 Individual protein Isocitrate lyase Candida albicans IC50 = 50.0 ug.mL-1 PMID[18507472]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1 Others Radical scavenging activity n.a. RC50 = 12.43 ug ml-1 PMID[18817444]
NPT2 Others Unspecified n.a. IC50 > 200.0 ug.mL-1 PMID[20795741]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC475029 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC476018
0.7945 Intermediate Similarity NPC474943
0.7945 Intermediate Similarity NPC475005
0.7808 Intermediate Similarity NPC475045
0.6962 Remote Similarity NPC475028
0.6962 Remote Similarity NPC476025
0.675 Remote Similarity NPC475044
0.675 Remote Similarity NPC475063
0.6625 Remote Similarity NPC475011
0.6375 Remote Similarity NPC475012
0.5584 Remote Similarity NPC474945
0.5584 Remote Similarity NPC476022
0.5309 Remote Similarity NPC204535
0.5309 Remote Similarity NPC46586
0.506 Remote Similarity NPC609806

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475029 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.52 Remote Similarity NPD6671 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data